Latest news with #AInvest
Economic Times
6 days ago
- Business
- Economic Times
Crisis-driven rally? Bitcoin and Gold soar as inflation looms and political heat rises
Bitcoin Hits a New High Amid Market Jitters Gold Joins Bitcoin in Safe-Haven Surge Live Events Bitcoin Recovers Quickly After Brief Dip on CPI Release Altcoins Join Bitcoin in Broad-Based Crypto Rally FAQs (You can now subscribe to our (You can now subscribe to our Economic Times WhatsApp channel As the United States grapples with mounting debt and inflation concerns, investors are flocking to assets that have served as safe havens in uncertain times, Bitcoin and gold, as per a week, Bitcoin surged past $123,000, climbing more than $10,000 in just a few days and hitting a new all-time high, as reported by GuruFocus. It's already up 14% for July, driven by growing anxiety over the US economy and the government's ballooning fiscal deficit, according to the report. A $316 billion shortfall in May has rekindled fears over long-term sustainability, prompting many to seek safety outside of traditional markets, according to the GuruFocus to trading expert Keith Alan, the price action fits a textbook "Cup and Handle" pattern, a signal of continued momentum, as per GuruFocus. But beyond technicals, it's deeper economic worries that seem to be driving the move, concerns over increased Treasury issuance, a wavering US dollar, and rising calls for Federal Reserve Chair Jerome Powell to step down, according to the READ: Stock rally sparks bold words from trading legend — his unexpected take is going viral Alongside Bitcoin, gold is also gaining ground as a safe-haven asset, with both markets reacting to a tense mix of political pressure, inflation jitters, and monetary uncertainty, as per data released this week didn't ease any of those concerns, as the Consumer Price Index for June showed a 2.7% increase year over year, which is slightly higher than May's 2.4%, as per the AInvest report. Core inflation, which excludes food and energy, rose to 2.9%, according to the crypto market wobbled just before the inflation report came, with Bitcoin briefly dipping below $116,000, as per AInvest. But it quickly bounced back, climbing past $118,000 once the numbers were out, with traders still betting on a potential rate cut in September, but the next round of data, specifically the Producer Price Index, could either reinforce or upend those expectations, according to the AInvest READ: No Reddit, no visa? Indian's US entry blocked after failing to share account details While Bitcoin was not the only cryptocurrency moving higher, even Ethereum rose over 6% in the past 24 hours, XRP, Binance Coin (BNB), Solana, and Dogecoin also saw gains, as reported by AInvest. XRP increased 3%, BNB by 2.4%, and both Solana and Dogecoin gained 5%, according to the people are nervous about inflation, debt, and political turmoil—and Bitcoin is seen as a safe place to park money during uncertainty, as per the GuruFocus like Bitcoin, is considered a hedge during times of inflation or market instability.
Time of India
6 days ago
- Business
- Time of India
Crisis-driven rally? Bitcoin and Gold soar as inflation looms and political heat rises
As the United States grapples with mounting debt and inflation concerns, investors are flocking to assets that have served as safe havens in uncertain times, Bitcoin and gold, as per a report. Bitcoin Hits a New High Amid Market Jitters This week, Bitcoin surged past $123,000, climbing more than $10,000 in just a few days and hitting a new all-time high, as reported by GuruFocus. It's already up 14% for July, driven by growing anxiety over the US economy and the government's ballooning fiscal deficit, according to the report. A $316 billion shortfall in May has rekindled fears over long-term sustainability, prompting many to seek safety outside of traditional markets, according to the GuruFocus report. Explore courses from Top Institutes in Select a Course Category Healthcare Management Others Design Thinking Public Policy CXO Data Science Product Management Technology Degree Data Analytics healthcare Data Science Project Management Operations Management MBA Leadership others MCA Finance PGDM Digital Marketing Artificial Intelligence Cybersecurity Skills you'll gain: Financial Analysis in Healthcare Financial Management & Investing Strategic Management in Healthcare Process Design & Analysis Duration: 12 Weeks Indian School of Business Certificate Program in Healthcare Management Starts on Jun 13, 2024 Get Details According to trading expert Keith Alan, the price action fits a textbook "Cup and Handle" pattern, a signal of continued momentum, as per GuruFocus. But beyond technicals, it's deeper economic worries that seem to be driving the move, concerns over increased Treasury issuance, a wavering US dollar, and rising calls for Federal Reserve Chair Jerome Powell to step down, according to the report. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Comment devenir un investisseur visionnaire eToro Market Updates En savoir plus Undo ALSO READ: Stock rally sparks bold words from trading legend — his unexpected take is going viral Gold Joins Bitcoin in Safe-Haven Surge Alongside Bitcoin, gold is also gaining ground as a safe-haven asset, with both markets reacting to a tense mix of political pressure, inflation jitters, and monetary uncertainty, as per GuruFocus. Live Events Bitcoin Recovers Quickly After Brief Dip on CPI Release Inflation data released this week didn't ease any of those concerns, as the Consumer Price Index for June showed a 2.7% increase year over year, which is slightly higher than May's 2.4%, as per the AInvest report. Core inflation, which excludes food and energy, rose to 2.9%, according to the report. The crypto market wobbled just before the inflation report came, with Bitcoin briefly dipping below $116,000, as per AInvest. But it quickly bounced back, climbing past $118,000 once the numbers were out, with traders still betting on a potential rate cut in September, but the next round of data, specifically the Producer Price Index, could either reinforce or upend those expectations, according to the AInvest report. ALSO READ: No Reddit, no visa? Indian's US entry blocked after failing to share account details Altcoins Join Bitcoin in Broad-Based Crypto Rally While Bitcoin was not the only cryptocurrency moving higher, even Ethereum rose over 6% in the past 24 hours, XRP, Binance Coin (BNB), Solana, and Dogecoin also saw gains, as reported by AInvest. XRP increased 3%, BNB by 2.4%, and both Solana and Dogecoin gained 5%, according to the report. FAQs Why is Bitcoin suddenly rising so fast? Because people are nervous about inflation, debt, and political turmoil—and Bitcoin is seen as a safe place to park money during uncertainty, as per the GuruFocus report. Why is gold also going up? Gold, like Bitcoin, is considered a hedge during times of inflation or market instability.
Forbes
08-07-2025
- Business
- Forbes
The Best 4 Healthcare Stocks To Buy Now In A Growing Sector
The relatively high dividends paid by some of these companies may prove worth the uncertain revenue ... More impact of Medicaid cuts. The healthcare sector is one of the largest in the U.S., with spending expected to account for 20% of the American economy as it reaches $5.2 trillion in 2025, according to NerdWallet. But the healthcare sector is likely to suffer considerably in the wake of the passage into law of the so-called Big Beautiful Bill. The industry's pain will result from a roughly $1 trillion reduction in Medicaid spending through 2034, according to the Congressional Budget Office. These cuts are likely to cause widespread pain. For example, 15.9 million Americans could lose Medicaid coverage, according to the Urban Institute. Hospitals' expenses for Medicaid patients could fall by $37 billion, estimated the Commonwealth Fund; to offset the lower revenue, hospitals, nursing homes, and doctors' offices could eliminate 477,000 jobs, according to the American Association of Medical Colleges. And many rural hospitals may be forced to close, forcing patients to travel further for care, noted the American Hospital Association. Nevertheless, the growth of companies providing high-value solutions to painful problems whose business models are relatively impervious to Medicaid cuts could provide attractive opportunities for investors. 4 Top Healthcare Stocks to Buy Now Healthcare consists of interconnected industries including the following: From this sector, the following stocks stand out. 1. Cardinal Health (CAH) Dublin, Ohio-based Cardinal Health distributes pharmaceuticals and medical products to more than 100,000 locations – controlling roughly 50% share of the market. Cardinal Health's stock rise can be attributed to a 2% boost, to $8.18, in analysts' 2025 consensus earnings per share due to stronger-than-expected growth and profitability in the company's pharmaceutical distribution and medical products segments, according to AInvest. Moreover, the stock could rise should the company report better than expected second quarter 2025 earnings. Due to Cardinal Health's 'cost discipline, supply chain stability, and rising demand for healthcare services post-pandemic,' analysts anticipate the company will report EPS of $2.04 – two cents above the Zacks consensus. Cardinal Health is on my list because investors have recognized the company is improving its operations, and many anticipate the company will exceed investor expectations. If demand remains strong and profitability rises, its shares could rise more. Medicaid cuts pose a significant risk to the healthcare sector, including Cardinal Health. Yet the company's diversified business model could enable it to withstand the worst damage from these cuts, AInvest reports. 2. Cencora (COR) Conshohocken, Pennsylvania-based Cencora – formerly known as AmerisourceBergen – is a drug wholesaler and contract research organization. Cencora's stock rise is likely due to the company's faster than expected growth in the first quarter of 2025. This growth resulted from higher unit volume, a boost in demand for diabetes and weight loss drugs, and a 2% increase, to $15.83, in the company's fiscal year 2025 earnings per share guidance, according to StockTwits. Although the pharmaceuticals distribution industry is intensely competitive, Cencora is expected to deliver solid profit growth and to exceed investor expectations. Specifically, investors anticipate the company's profits will rise 12.8% over the next five years in the wake of delivering 6% better than expected EPS for each of 'the trailing four quarters,' noted Zacks. I included Cencora due to its track record of beating investor expectations. However, Medicaid cuts could reduce drug sales as millions of Americans lose their Medicaid coverage – thus cutting into Cencora's revenues, noted AInvest. However, the company's focus on growing areas like specialty pharmaceuticals and its acquisition of a retinal care company could help offset the likely negative effects of Medicaid policy changes, according to Zacks. 3. Hinge Health (HNGE) San Francisco-based Hinge Health develops healthcare software for musculoskeletal care, acute injury, chronic pain and post-surgical rehabilitation. The company's stock market rise flowed from its torrid revenue growth – up 420% in the quarter ending in March, according to Google Finance. Hinge Health stock rose 23% after the company's May 2025 initial public offering. The stock is propelled by strong investor confidence in the company's digital musculoskeletal care platform and positive financial performance, according to BusinessInsider. Hinge Health is on my list for these same reasons. What's more, since the company primarily targets self-insured employers and is partnering with major health plans to expand into the Medicare Advantage market, this diversification could mitigate the pain of Medicaid cuts, noted AlphaSense. Nevertheless, Hinge Heath's stock price will likely rise only if the company beats expectations and raises guidance when the company next reports quarterly earnings. 4. Gilead Sciences (GILD) Foster City, California-based Gilead Sciences researches and develops antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza and COVID-19. Gilead's stock rise resulted from expectations-beating earnings in the first quarter, coupled with an optimistic forecast for 2025 EPS due to strong sales of existing products and new treatments, according to Reuters. In addition, the company's 99.9% effective HIV drug Sunienca received regulatory approval in the U.S. and Europe. Gilead is on my list because of its strong growth and bright prospects. However, since about 25% of the company's revenue is exposed to Medicaid – notably to its HIV drug Biktarvy – the Medicaid cuts could reduce the company's total revenue by 1% to 2%, according to Fierce Pharma. Bottom Line Healthcare is a huge, complex industry. Medicaid cuts could take a sizable bite out of many industry participants' revenue. The four companies described above – Cardinal Health, Cencora, Hinge Health, and Gilead – are likely more impervious to these cuts than owners of hospitals – particularly rural ones. Investors should scrutinize whether the relatively high dividends paid by some of these companies are worth the uncertain revenue impact of the Medicaid cuts.
Forbes
08-07-2025
- Business
- Forbes
SoFi Stock Up 36% — May Rise On Crypto, Student Loan Policy Boosts
SoFi Technologies stock is on a roll due to favorable crypto rulings from bank regulator and student loan changes in the Big, Beautiful Bill Act SoFi logo sign on the facade of an art deco style office building, San Francisco, California, May ... More 27, 2025. (Photo by Smith Collection/Gado/Getty Images) Gado via Getty Images Key Facts Lower federal student-loan caps in the Big Beautiful Bill Act could drive more graduate student borrowers to SoFi and other private-student lenders, according to the Wall Street Journal SoFi's cryptocurrency services will likely benefit by the end of 2025 from The Office of the Comptroller of the Currency's interpretive regulatory letters permitting nationally chartered banks to 'custody crypto assets and execute blockchain payments,' reported AInvest . SoFi stock has risen 36% in 2025 as of July 7. However, analysts view the shares as nearly 23% overvalued, TipRanks noted. Shares of San Francisco-based financial services platform operator SoFi Technologies have risen 36% this year. That is an improvement since the end of April when the stock had risen 22% after 'SoFi exceeded Q1 2025 expectations and raised full-year guidance, driven by record member, product, and fee-based revenue growth,' according to my April Forbes post. At the time, SoFi faced considerable regulatory uncertainty — specifically related to student loans and cryptocurrency. Now there is much more clarity on these two topics — which has helped send SoFi stock up. Here's how: The Big Beautiful Bill Act reduced how much graduate students can borrow from the federal government which is likely to drive borrowers to SoFi and other private-student lenders. OCC regulatory letters eliminate much of the regulatory uncertainty related to SoFi's cryptocurrency services — which should stimulate demand and boost revenue. While declining to comment on the BBBA, SoFi expects to benefit from limits to federal student lending. We will 'absolutely capture that opportunity,' SoFi CEO Anthony Noto said on an April earnings featured in a Bloomberg report . A sour note in this picture is somewhat gloomy Wall Street analyst 12-month stock price forecasts which suggest SoFi stock is 23% over-valued. However, those analysts could be wrong and I expect the company to beat expectations and raise guidance when SoFi issues its second quarter report later this month. (Disclosure: I am a SoFi shareholder). In April, SoFi reported first quarter results that beat expectations and the company raised its guidance for 2025. For example, SoFi's first quarter adjusted net revenue rose 33% to $772 million — which beat the FactSet consensus by $33 million. Moreover, SoFi's q1 earnings per share of six cents was double the FactSet view, I wrote in Forbes . SoFi also raised 2025 guidance for key metrics. The company raised by 1% its previous net revenue outlook to $3.273 billion while adding 5.7% to SoFi's 2025 EPS guidance: now $0.275 per share, I noted. In April, the OCC's looser bank crypto policies had been announce; however, government policies towards federal student loan limits were unresolved. At the time, SoFi anticipated it would 'offer crypto investing by year-end, barring unforeseen circumstances,' Noto told CNBC . The recently passed BBBA eliminates April's uncertainty regarding changes to federal student loans. How Sofi Will Benefit From Crypto Clarity The OCC's rulings permitting banks to custody cryptocurrency and make payments on the blockchain enhance two SoFi revenue streams: crypto trading and remittance processing on the blockchain. When it comes to crypto trading, SoFi has an advantage over platforms such as Coinbase or Kraken. Specifically, with 30% of adults having adopted crypto, SoFi offers users a one-stop shopping service those rivals do not provide. More specifically, in addition to Bitcoin and Ethereum trading, and crypto-collateralized lending this year, SoFi can also provide lending, savings, and insurance services to those younger, more tech-savvy SoFi customers, noted AInvest . The $90 billion market for cross-border payments is dominated by 'high-cost legacy providers like Western Union and MoneyGram,' AInvest reported. In 2024, SoFi launched a blockchain-powered remittance service which offers compelling value to customers. By enabling users to transfer at any time using stablecoins over the blockchain, SoFi 'eliminates currency conversion fees and reduces processing times from days to minutes,' according to AInvest . After adding 800,000 new users in the first quarter — many from this remittance service — recurring remittance fees (in the range of 1% to 3% of the transaction value, could supplement SoFi's loan and wealth management businesses. By 2030, the market for fintech blockain is expected to reach $49 billion — a market on which SoFi is well-positioned to capitalize, according to AInvest . Sofi Student Lending Revenue May Rise On Bbba Student Loan Limits Since SoFi's original business was student loan refinancing, the BBBA offers the company a significant growth opportunity. For example, new federal loan caps will lower federal borrowing some 28% to $100,000 for graduate students and 11% to $200,000 for medical school, the Journal reported. SoFi is anticipated to be a leader in making up the difference between the old and new federal student loan caps — most notable for student loan refinancing. 'Refinancing demand should also accelerate with the resumption of debt collection and higher payments,' Citizens Financial Group head of fintech research Devin Ryan told Bloomberg . 'SoFi has terrific market share in student lending, and, with a number of lenders pulling back in recent years, we expect the firm to be a primary beneficiary of increasing demand,' Ryan added. SoFi stock — 13.7% of which is sold short, noted the Journal — could rise further. To be sure, the shares face headwinds as reflected in analysts' 12-month price target suggesting the stock is 23% too high. What's more, risks include competition from Block and Revolut in blockchain remittance processign and rising unemployment. The bullish case depends on SoFi reaching $3.5 billion to $4 billion in 2026 revenue — justifying the company's 67x P/E, noted AIinvest . Disclosure: I own shares in SoFi Technologies – starting as an angel investor in 2014.
Yahoo
04-07-2025
- Business
- Yahoo
Smart Money Buys the Solar Dip
When the market reacts sharply to short-term pressures, long-term fundamentals often get obscured. That may be the case with Enphase Energy (NASDAQ: ENPH). Solar stocks have struggled in 2025. Enphase shares are down roughly 65% from 2024 highs, impacted by rising interest rates, shifting U.S. policy incentives, and slowing rooftop demand. Sentiment has weakened, and many investors have exited the sector, reallocating toward larger-cap utilities or oil and gas producers perceived as safer amid policy uncertainty. But Enphase remains a key player in residential solar hardware. It holds more than 50% of the U.S. residential microinverter market and a substantial global footprint. While its second-quarter revenue of $356 million fell short of expectations, much of the shortfall is tied to near-term pressures: modest tariff increases on battery cells, policy adjustments in California's NEM 3.0 framework, and broader deceleration in home solar installations due to rate sensitivity. These are real challenges. But they are not necessarily structural. Elevated interest rates have clearly dampened rooftop solar economics, particularly for middle-income homeowners relying on financing. Yet this is a cyclical dynamic—not a reflection of declining relevance for distributed solar technologies. According to a recent analysis from AInvest (but before the 'Big Beautiful Bill' passed the Senate), Enphase's longer-term value proposition remains intact. The company's intellectual property, installer loyalty, and 40%+ gross margins (in normalized periods) point to a business model that could remain competitive even in a tighter policy environment. Enphase's energy management software platform also positions it to play a larger role in the grid-edge architecture utilities are beginning to July 1, 2025, the U.S. Senate passed its reconciliation bill as part of the "Big Beautiful Bill" package. The legislation confirmed a phasedown of the Section 25D residential solar tax credit, dropping from 30% in 2025 to 18% in 2026, 6% in 2027, and eliminating the credit entirely by 2028. While the bill still requires House approval and reconciliation, the direction is now clearer. Enphase shares initially dropped on early headlines but closed only 2.3% lower, indicating a market recalibration after details emerged. More recent commentary following the vote has been restrained. RBC Capital Markets called the impact "modest," noting that the market had likely priced in much of the downside before the bill passed. Raymond James observed that the extended timeline preserved a meaningful installation window through 2027, allowing companies like Enphase to adapt rather than react. A July 2 Seeking Alpha review emphasized two dynamics: a likely installation surge in late 2025 as buyers move to lock in credits, and the potential for interest rates to moderate into 2026, offsetting some of the loss in tax subsidy support. Analysts also noted Enphase's growing exposure to international markets and commercial storage as buffers to its U.S. residential exposure. In that light, the Senate vote is better understood as a transition (yet another), not a break. Enphase's fundamentals, particularly its diversification by geography and product, offer some insulation from the evolving credit landscape. The July 1 sell-off may have reflected headline sensitivity more than a permanent change in demand structure. In other words, for Enphase, the development is consequential, but not conclusive. While the U.S. residential segment does rely on 25D to support financing and uptake, the legislation provides a clear transition window through 2027. Analysts at J.P. Morgan noted the extended credit period offers "project visibility through the end of the decade," while Mizuho described the Senate version as more manageable than prior proposals. Morgan Stanley, though broadly bearish on renewables in this environment, acknowledged the structure still supports near-term sales pipelines. Enphase shares initially dropped 17% on policy signals, but the stock closed just 2.3% lower on July 1, underscoring how quickly sentiment can shift once details are parsed. Importantly, much of Enphase's volume is now tied to international markets, with growing exposure to Australia, Germany, and Italy. It is also extending its footprint in EV charging, commercial storage, and grid services, areas not tied directly to 25D. In this light, the Senate vote marks a policy pivot, not a strategic dead end. The market's reaction may have captured headline risk, but it likely underestimated the company's structural levers, geographic flexibility, and the transitional protections embedded in the bill. Institutional and insider behavior offers some insight. In Q1, Abacus FCF Advisors increased their ENPH holdings by 376%. CEO Badri Kothandaraman also purchased shares at around $46, indicating internal confidence even amid volatility. Other long-horizon investors such as Baillie Gifford and T. Rowe Price have held their positions steady, suggesting that large pools of capital are not treating this as an exit moment. Valuation has compressed significantly. As of July 1, 2025, Enphase trades at approximately 3.77x forward sales, with a double-digit free cash flow yield—levels that historically have drawn interest from long-term investors. Trefis recently highlighted that renewed policy clarity or stabilization in rates could be catalysts for recovery. More importantly, even under current conditions, the company remains free cash flow positive and maintains a strong balance sheet. The company is also expanding its product suite. In July, it began shipping the IQ EV Charger 2 in Australia and New Zealand, reinforcing its position in the integrated home energy ecosystem. This complements its existing inverter and battery offerings and reflects a shift toward broader energy management. Enphase's modular architecture makes it easier for homeowners to add EV charging or energy storage incrementally, which supports upsell potential and enhances customer stickiness. The competitive landscape is also evolving. While Tesla, Huawei, and SolarEdge offer competing solutions, Enphase's focus on the residential installer channel in the U.S. gives it a defensible position. The company's approach to hardware-software integration, and its responsiveness to installer feedback, have historically translated into high retention and strong gross margins. Operationally, Enphase is responding to cost pressures by shifting production toward South Korea and Mexico, which may support margin stabilization in the back half of 2025. This shift is also designed to mitigate the impact of U.S. tariffs on Chinese battery cells, which have increased by 2-8% this year under updated Section 301 trade provisions. Enphase has also signaled that it will begin leveraging automation in its Mexican facilities to lower unit assembly costs and improve quality control. A Long-Term Bet on Persistence Enphase is facing real pressures, and its near-term outlook remains uncertain. But the current valuation appears to reflect more than just fundamental risk. Instead, it reflects the market's reaction to legislative uncertainty and broader sentiment toward clean energy equities. This kind of dislocation isn't unusual in cyclical industries, especially when policy and capital costs are both in flux. The business retains meaningful market share, continues to invest in new product lines, and has not seen capital flight from all corners. In fact, several long-duration investors have increased their positions in recent months. Handelsbanken Fonder AB boosted its stake by 181.9% in Q1 2025, now holding over 747,000 shares. Oppenheimer & Co. increased its position by 94.2%, while Janney Montgomery Scott LLC raised its holdings by 248.3%. QRG Capital Management initiated a new position, and GAMMA Investing LLC expanded its exposure by over 10,000%. These moves suggest that some institutional investors are taking a longer-term view and see current valuation levels as an opportunity rather than a signal to exit. Its balance sheet remains sound, and its operating model has shown resilience through previous periods of volatility. For those willing to take a longer view, the recent sell-off may represent more dislocation than decline. Enphase may not be positioned for immediate upside. But the assumptions now priced into the stock deserve closer scrutiny, especially as the policy and rate environment evolves. If inflation continues to moderate and tax credit support stabilizes, the current market narrative could shift quickly. Until then, this is a company worth watching, not because the story is easy, but because the fundamentals haven't disappeared just because the headlines have. By Charles Kennedy for More Top Reads From this article on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
